Efficacy of a 1-week course of proton-pump inhibitor-based triple therapy for eradicating Helicobacter pylori in patients with and without chronic renal failure.
Mak, Siu-ka; Loo, Ching-kong; Wong, Alfred M C; Wong, Ping-nam; Lo, Kin-yee; Tong, Gensy M W; Lam, Eric K M; Wong, Andrew K M.
Am J Kidney Dis
; 40(3): 576-81, 2002 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-12200810
Evaluation of the efficacy and safety of the hybrid scheme for eradication therapy of Helicobacter pylori infection.
Efficacy and safety of the use of rebamipide in the scheme of triple eradication therapy of Helicobacter pylori infection: a prospective randomized comparative study.
THE LONG - TERM RESULTS OF USEFUL ERADICAION PATIENTS WITH PEPTIC ULSERS (a five-year monitoring).
First-line treatment of Helicobacter pylori in Lebanon: Comparison of bismuth-containing quadruple therapy versus 14-days sequential therapy.
The Effect of Probiotics on Gut Microbiota during the Helicobacter pylori Eradication: Randomized Controlled Trial.
Helicobacter pylori Eradication with Proton Pump Inhibitors or Potassium-Competitive Acid Blockers: The Effect of Clarithromycin Resistance.
Antibiomania : penser au syndrome maniaque secondaire à une antibiothérapie.
[Amoxicillin-Clarithromycin-Containing Bismuth Quadruple Therapy for Primary Eradication of Helicobacter pylori].
Comparison Between 10- and 14-Day Hybrid Regimens for Helicobacter pylori Eradication: A Randomized Clinical Trial.
Personalized therapy for Helicobacter pylori: CYP2C19 genotype effect on first-line triple therapy.